公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | East Asian subgroup analysis of a randomized, double-blind, phase 3 study of docetaxel and ramucirumab versus docetaxel and placebo in the treatment of stage IV non-small cell lung cancer following disease progression after one prior platinum-based therapy (REVEL) | Park K.; Kim J.-H.; Cho E.K.; Kang J.-H.; JIN-YUAN SHIH ; Zimmermann A.H.; Lee P.; Alexandris E.; Puri T.; Orlando M. | Cancer Research and Treatment | 19 | 15 | |
1996 | Echogenic floating spherules as a sonographic sign of cystic teratoma of mediastinum: Correlation with CT and pathologic findings | JIN-YUAN SHIH ; HAO-CHIEN WANG ; YIH-LEONG CHANG ; YEUN-CHUNG CHANG ; Lee Y.-C.; PAN-CHYR YANG | Journal of Ultrasound in Medicine | 2 | 2 | |
2020 | Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs | CHIA-HAO CHANG ; Lee C.-H.; JEN-CHUNG KO ; LIH-YU CHANG ; Lee M.-C.; Zhang J.-F.; JANN-YUAN WANG ; JIN-YUAN SHIH ; CHONG-JEN YU | Frontiers in Oncology | 9 | 8 | |
2020 | The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation | SHANG-GIN WU ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Therapeutic Advances in Medical Oncology | 16 | 15 | |
2019 | Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations | Wu J.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH | Clinical Lung Cancer | 40 | 32 | |
2011 | Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; YEUN-CHUNG CHANG ; CHIH-HSIN YANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Clinical Cancer Research | 412 | 364 | |
2016 | Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer | Wu J.-Y.; JIN-YUAN SHIH | OncoTargets and Therapy | 32 | 28 | |
2012 | Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy | Hwang C.-L.; CHONG-JEN YU ; JIN-YUAN SHIH ; PAN-CHYR YANG ; Wu Y.-T. | Supportive Care in Cancer | 119 | 105 | |
2021 | Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions | KAI-LUN YU ; SHUN-MAO YANG ; Ko, Huan-Jang; Tsai, Hui-Yu; JEN-CHUNG KO ; CHING-KAI LIN ; CHAO-CHI HO ; JIN-YUAN SHIH | Respiration | 19 | 18 | |
2023 | Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study | Chiu, Chao-Hua; Lin, Meng-Chih; Wei, Yu-Feng; Chang, Gee-Chen; Su, Wu-Chou; Hsia, Te-Chun; Su, Jian; Wang, Anne Kuei-Fang; Jen, Min-Hua; Puri, Tarun; JIN-YUAN SHIH | Targeted oncology | 0 | 0 | |
2016 | Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 63 | 51 | |
2012 | Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma | TZU-HSIU TSAI ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHEN-TU WU ; Tsai M.-F.; Wei P.-F.; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 22 | 26 | |
2011 | EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | Annals of Surgical Oncology | 48 | 43 | |
2009 | EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment | Huang C.-L.; CHIH-HSIN YANG ; KUN-HUEI YEH ; Hu F.-C.; KUAN-YU CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; ANN-LII CHENG ; PAN-CHYR YANG | Lung Cancer | 43 | 36 | |
2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C. | Carcinogenesis | 13 | 12 | |
2005 | EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer [2] (multiple letters) | JIN-YUAN SHIH ; Gow C.-H.; PAN-CHYR YANG | New England Journal of Medicine | 166 | 145 | |
2015 | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway | Tsai M.-F.; Chang T.-H.; SHANG-GIN WU ; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG ; JIN-YUAN SHIH | Scientific Reports | 48 | 43 | |
2023 | Electronic nose in differentiating and ascertaining clinical status among patients with pulmonary nontuberculous mycobacteria: A prospective multicenter study | MENG-RUI LEE ; Huang, Hung-Ling; Huang, Wei-Chang; Wu, Shang-Yu; Liu, Pang-Chun; Wu, Jui-Ching; Cheng, Meng-Hsuan; Sheu, Chau-Chyun; Tang, Kea-Tiong; JANN-YUAN WANG ; CHAO-CHI HO ; JIN-YUAN SHIH ; Chong, Inn-Wen | The Journal of infection | 0 | 0 | |
1997 | Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome | JIN-YUAN SHIH ; Yang S.-C.; CHONG-JEN YU ; Wu H.-D.; Liaw Y.-S.; Wu R.; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 10 | 13 | |
2012 | EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR | SHANG-GIN WU ; YAO-WEN KUO ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 90 | 72 | |